InvestSMART

Percheron Therapeutics Limited (ASX: PER) - Announcements

Current share price for PER : $0.004 0.001 (33.33%)+

ASX company news and announcements for Percheron Therapeutics Limited (PER) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Percheron Therapeutics Limited (PER) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Percheron Therapeutics Limited (PER), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Percheron Therapeutics Limited (PER)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Trading Halt 16 Dec 2024 9:19AM $0.059 $0.004 fallen by 93.22%
$6 Reorganisation of US Quoted Securities 3 Dec 2024 9:31AM $0.071 $0.004 fallen by 94.37%
$6 Clinical Trial Update 2 Dec 2024 9:03AM $0.074 $0.004 fallen by 94.59%
$6 Resignation of Joint Company Secretary 2 Dec 2024 8:55AM $0.074 $0.004 fallen by 94.59%
$6 Notification regarding unquoted securities - PER 29 Nov 2024 5:05PM $0.074 $0.004 fallen by 94.59%
$6 Change of Director's Interest Notice - Dr James Garner 28 Nov 2024 8:44AM $0.071 $0.004 fallen by 94.37%
$6 Notice under S708A 27 Nov 2024 8:54AM $0.068 $0.004 fallen by 94.12%
$6 Application for quotation of securities - PER 26 Nov 2024 9:32AM $0.074 $0.004 fallen by 94.59%
$6 Change of Director's Interest Notice - Dr Ben Gil Price 25 Nov 2024 4:42PM $0.074 $0.004 fallen by 94.59%
$6 Change of Director's Interest Notice Dr James Garner 25 Nov 2024 4:40PM $0.074 $0.004 fallen by 94.59%
$6 Notification regarding unquoted securities - PER 25 Nov 2024 4:37PM $0.074 $0.004 fallen by 94.59%
$6 Proposed issue of securities - PER 21 Nov 2024 3:03PM $0.074 $0.004 fallen by 94.59%
$6 Proposed issue of securities - PER 21 Nov 2024 2:56PM $0.077 $0.004 fallen by 94.81%
$6 Results of the Annual General Meeting 21 Nov 2024 2:45PM $0.077 $0.004 fallen by 94.81%
$6 Annual General Meeting Management Presentation 21 Nov 2024 9:48AM $0.078 $0.004 fallen by 94.87%
$6 Annual General Meeting - Chair's Address 21 Nov 2024 9:45AM $0.078 $0.004 fallen by 94.87%
$6 Withdrawal of Resolutions from the Annual General Meeting 21 Nov 2024 9:43AM $0.078 $0.004 fallen by 94.87%
$6 Change in substantial holding 15 Nov 2024 4:39PM $0.079 $0.004 fallen by 94.94%
$6 Change of Director's Interest Notice - Dr James Garner 14 Nov 2024 10:08AM $0.082 $0.004 fallen by 95.12%
$6 Application for quotation of securities - PER 14 Nov 2024 10:00AM $0.082 $0.004 fallen by 95.12%
$6 Results of Share Purchase Plan 13 Nov 2024 8:39AM $0.085 $0.004 fallen by 95.29%
$6 Quarterly Activities Report and Appendix 4C 31 Oct 2024 8:33AM $0.081 $0.004 fallen by 95.06%
$6 Percheron launches post-trial access program 28 Oct 2024 9:34AM $0.081 $0.004 fallen by 95.06%
$6 Share Purchase Plan Offer Booklet 28 Oct 2024 8:27AM $0.081 $0.004 fallen by 95.06%
$6 Notice under S708A 25 Oct 2024 8:23AM $0.079 $0.004 fallen by 94.94%

101 - 125 of 178 results

Page 5 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.